Business Description
Mercury Biopharmaceutical Corp
ISIN : TW0006932007
Total Employee Number:
10Description
Mercury Biopharmaceutical Corp focuses on the development of drugs for unmet medical needs. It offers a development platform focusing on rapid release and free adjustable doses. Its 3D powder bonding method (binder jetting) combines powder and special molding adhesive and stacks them in layers.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 3.92 | |||||
Equity-to-Asset | 0.79 | |||||
Debt-to-Equity | 0.19 | |||||
Debt-to-EBITDA | -0.77 | |||||
Piotroski F-Score | 1/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -20.7 | |||||
3-Year EPS without NRI Growth Rate | -24.7 | |||||
3-Year FCF Growth Rate | 17.8 | |||||
3-Year Book Growth Rate | 5.9 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 27.62 | |||||
9-Day RSI | 31.78 | |||||
14-Day RSI | 33.89 | |||||
3-1 Month Momentum % | -9.25 | |||||
6-1 Month Momentum % | -27.16 | |||||
12-1 Month Momentum % | -27.64 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 8.84 | |||||
Quick Ratio | 8.84 | |||||
Cash Ratio | 8.28 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.9 | |||||
Shareholder Yield % | 0.18 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROE % | -26.46 | |||||
ROA % | -21.26 | |||||
ROIC % | -58.41 | |||||
3-Year ROIIC % | -139.25 | |||||
ROC (Joel Greenblatt) % | -71.7 | |||||
ROCE % | -22.42 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PB Ratio | 11.26 | |||||
Price-to-Tangible-Book | 11.63 | |||||
EV-to-EBIT | -36.48 | |||||
EV-to-EBITDA | -44.26 | |||||
EV-to-FCF | -41.52 | |||||
Price-to-GF-Value | 0.16 | |||||
| Price-to-Net-Current-Asset-Value | 21.18 | |||||
| Price-to-Net-Cash | 23.72 | |||||
Earnings Yield (Greenblatt) % | -2.75 | |||||
FCF Yield % | -2.29 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Mercury Biopharmaceutical Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | |||
| EPS (TTM) (NT$) | -0.162 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | -0.75 | ||
| 3-Year Sortino Ratio | -1.04 | ||
| Volatility % | 81.39 | ||
| 14-Day RSI | 33.89 | ||
| 14-Day ATR (NT$) | 0.324537 | ||
| 20-Day SMA (NT$) | 6.227 | ||
| 12-1 Month Momentum % | -27.64 | ||
| 52-Week Range (NT$) | 4.95 - 12.2 | ||
| Shares Outstanding (Mil) | 417.09 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Mercury Biopharmaceutical Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Mercury Biopharmaceutical Corp Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Mercury Biopharmaceutical Corp Frequently Asked Questions
What is Mercury Biopharmaceutical Corp(ROCO:6932)'s stock price today?
The current price of ROCO:6932 is NT$5.93. The 52 week high of ROCO:6932 is NT$12.20 and 52 week low is NT$4.95.
When is next earnings date of Mercury Biopharmaceutical Corp(ROCO:6932)?
The next earnings date of Mercury Biopharmaceutical Corp(ROCO:6932) is .
Does Mercury Biopharmaceutical Corp(ROCO:6932) pay dividends? If so, how much?
Mercury Biopharmaceutical Corp(ROCO:6932) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Mercury Biopharmaceutical Corp
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers